Find latest Non-Small Cell Lung Cancer videos · 500+ videos

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs. Placebo in Stage IB-IIIA RET+ NSCLC"

164 views
June 14, 2024

Chapters

Introduction to RET & Selpercatinib

00:00

LIBRETTO-001 Trial & Results

01:59

Adverse Events & Management

04:03

Phase III Trial & Efficacy

06:02

LIBRETTO-432 Trial Design & Goals

07:55

Comments 0
Login to view comments. Click here to Login